Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Brunner

Showing results (121-130 of 200) with videos related to

Pageof 20
Sort By:
Pathology|March 31, 2010
Differential cell cycle and proliferation marker expression in ductal pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia (PanIN)Eva Karamitopoulou, Inti Zlobec, Luigi Tornillo, et al.
European Radiology|December 13, 2019
MRI targeted single fraction HDR Brachytherapy for localized Prostate Carcinoma: a feasibility study of focal radiation therapy (ProFocAL)Frank Fischbach, Peter Hass, Daniel Schindele, et al.
Journal of Virology|May 22, 2002
Effects of antiretroviral drugs on human immunodeficiency virus type 1-induced CD4(+) T-cell deathJérôme Estaquier, Jean-Daniel Lelièvre, Frédéric Petit, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 7, 2022
Shift of radiotherapy use during the first wave of the COVID-19 pandemic? An analysis of German inpatient dataDaniel Medenwald, Thomas Brunner, Hans Christiansen, et al.
Radiation Oncology (London, England)|July 29, 2021
Functional and mutational analysis after radiation and cetuximab treatment on prostate carcinoma cell line DU145Raik Schneider, Günther Gademann, Hans-Joachim Ochel, et al.
Veterinary Research|July 28, 2009
Phenotyping, functional characterization, and developmental changes in canine intestinal intraepithelial lymphocytesNicole Luckschander, Nadia S Pfammatter, Daniel Sidler, et al.
Oncoimmunology|July 4, 2012
Colon cancer cells produce immunoregulatory glucocorticoidsDaniel Sidler, Pietro Renzulli, Christina Schnoz, et al.
Cell Death and Differentiation|April 1, 2017
PU.1 supports TRAIL-induced cell death by inhibiting NF-κB-mediated cell survival and inducing DR5 expressionAladin Haimovici, Magali Humbert, Elena A Federzoni, et al.
Molecular Cancer Therapeutics|November 9, 2021
The Mitochondrial Disruptor Devimistat (CPI-613) Synergizes with Genotoxic Anticancer Drugs in Colorectal Cancer Therapy in a Bim-Dependent MannerCarina Arnold, Philipp Demuth, Nina Seiwert, et al.
Biochemical Pharmacology|January 15, 2022
Nitazoxanide and related thiazolides induce cell death in cancer cells by targeting the 20S proteasome with novel binding modesZirui Lü, Xiaona Li, Kebin Li, et al.
Pageof 20

Showing results (121-130 of 200) with videos related to

Sort By:
Pageof 20
Pathology|March 31, 2010
Differential cell cycle and proliferation marker expression in ductal pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia (PanIN)Eva Karamitopoulou, Inti Zlobec, Luigi Tornillo, et al.
European Radiology|December 13, 2019
MRI targeted single fraction HDR Brachytherapy for localized Prostate Carcinoma: a feasibility study of focal radiation therapy (ProFocAL)Frank Fischbach, Peter Hass, Daniel Schindele, et al.
Journal of Virology|May 22, 2002
Effects of antiretroviral drugs on human immunodeficiency virus type 1-induced CD4(+) T-cell deathJérôme Estaquier, Jean-Daniel Lelièvre, Frédéric Petit, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 7, 2022
Shift of radiotherapy use during the first wave of the COVID-19 pandemic? An analysis of German inpatient dataDaniel Medenwald, Thomas Brunner, Hans Christiansen, et al.
Radiation Oncology (London, England)|July 29, 2021
Functional and mutational analysis after radiation and cetuximab treatment on prostate carcinoma cell line DU145Raik Schneider, Günther Gademann, Hans-Joachim Ochel, et al.
Veterinary Research|July 28, 2009
Phenotyping, functional characterization, and developmental changes in canine intestinal intraepithelial lymphocytesNicole Luckschander, Nadia S Pfammatter, Daniel Sidler, et al.
Oncoimmunology|July 4, 2012
Colon cancer cells produce immunoregulatory glucocorticoidsDaniel Sidler, Pietro Renzulli, Christina Schnoz, et al.
Cell Death and Differentiation|April 1, 2017
PU.1 supports TRAIL-induced cell death by inhibiting NF-κB-mediated cell survival and inducing DR5 expressionAladin Haimovici, Magali Humbert, Elena A Federzoni, et al.
Molecular Cancer Therapeutics|November 9, 2021
The Mitochondrial Disruptor Devimistat (CPI-613) Synergizes with Genotoxic Anticancer Drugs in Colorectal Cancer Therapy in a Bim-Dependent MannerCarina Arnold, Philipp Demuth, Nina Seiwert, et al.
Biochemical Pharmacology|January 15, 2022
Nitazoxanide and related thiazolides induce cell death in cancer cells by targeting the 20S proteasome with novel binding modesZirui Lü, Xiaona Li, Kebin Li, et al.
Pageof 20